Publications by authors named "Lionel D Lewis"

Claim this Profile
I
Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center.
Jenna K Green, Laura J Hackett, Donald C Green, Sophie J Deharvengt, Gabriel A Brooks, Lionel D Lewis

J Oncol Pharm Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer.
Gabriel A Brooks, Dylan B Ness, Kathryn C Hourdequin, Gregory H Ripple, Manik Amin, Lionel D Lewis

Cancer Chemother Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.
Nadine Norton, Nicholas B Larson, Gregory D Jenkins, Jan H Beumer, Brooke Langevin, Lionel D Lewis

Clin Transl Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology in space for astronauts and earthlings.
Jens Jordan, Lionel D Lewis

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical pharmacology and therapeutics course for graduating medical students at Dartmouth: Preparation for internship and residency.
David W Nierenberg, Lionel D Lewis

Br J Clin Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Space travel-associated motion sickness and its treatment.
Jay C Buckey, Mimi Lan, Lionel D Lewis

Br J Clin Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.
Crismita Dmello, Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz, Lionel D Lewis

Neurooncol Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Stealth Liposome-Based Nanoparticles Encapsulating the ACAT1/SOAT1 Inhibitor F26: Efficacy and Toxicity Studies In Vitro and in Wild-Type Mice.
Junghoon Lee, Adrianna L De La Torre, Felix L Rawlinson, Dylan B Ness, Lionel D Lewis

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma.
John T Lear, Linda M Morris, Dylan B Ness, Lionel D Lewis

Expert Rev Clin Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran, Lionel D Lewis

Cancer Chemother Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Randolph J Noelle, J Louise Lines, Lionel D Lewis, Robert E Martell, Thierry Guillaudeux

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran, Lionel D Lewis

Cancer Chemother Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice.
Adrianna L De La Torre, Thao N Huynh, Catherine C Y Chang, Darcy B Pooler, Dylan B Ness, Lionel D Lewis

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701).
Kathryn J Ruddy, David Zahrieh, Jun He, Blake Waechter, Julianne L Holleran, Lionel D Lewis

Semin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).
Michael J Morris, Glenn Heller, David W Hillman, Olivia Bobek, Charles Ryan, Lionel D Lewis

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
Dylan B Ness, Darcy B Pooler, Steven Ades, Brian J Highhouse, Bridget M Labrie, Lionel D Lewis

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients.
Joseph D Phillips, Darcy B Pooler, Dylan B Ness, Kayla Fay, Steven Tau, Lionel D Lewis

Br J Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population.
Grace R Williams, Gregory J Tsongalis, Lionel D Lewis, Rachael E Barney, Leanne J Cook

J Appl Lab Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VISTA expression and patient selection for immune-based anticancer therapy.
Alexander S Martin, Michael Molloy, Andrey Ugolkov, Reinhard W von Roemeling, Randolph J Noelle, Lionel D Lewis

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Pallawi Torka, Swetha Kambhampati Thiruvengadam, Lu Chen, Xiaoguang Wang, Canping Chen, Lionel D Lewis

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization.
Robert Likic, James W Dear, Lionel D Lewis

Br J Clin Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
Darcy B Pooler, Dylan B Ness, Alexey V Danilov, Bridget M Labrie, Tor D Tosteson, Lionel D Lewis

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Cabozantinib in Human Plasma by LC-MS/MS.
Reyna Jones, Julianne Holleran, Robert A Parise, Michelle A Rudek, Jennifer Chan, Lionel D Lewis

J Chromatogr Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL.
Matthew J Wieduwilt, Jun Yin, Meir Wetzler, Geoffrey L Uy, Bayard L Powell, Lionel D Lewis

Blood Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia.
Itzel Y Rojas, Benjamin J Moyer, Carol S Ringelberg, Owen M Wilkins, Darcy B Pooler, Lionel D Lewis

Obesity (Silver Spring)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis